Skip to content
A Blog by Biocon

A Blog by Biocon

  • Home
  • About Us
  • Biocon Biologics
    • Biosimilars
    • Biocon Biologics @ IDF Congress 2019
      • Speaker Profiles
    • Itolizumab (ALZUMAb®) : Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19
  • Healthcare
  • Innovation
  • Disease Epidemiology
  • Vodcast
  • Bioconites Corner
    • Work From Home
    • Campaigns
      • Har Ghar Tiranga
      • Mother’s Day
      • Lupus Day
  • Policy
  • Comments Policy
  • Contact

Month: January 2017

January 12, 2017January 12, 2017 Biocon Human Resource, Policy

Strategic HR for Today’s Biotech M&As

Amitava Saha, Sr. VP & Head HR, Biocon shares his views on the role of Strategic HR in ensuring the success of today’s biotech M&As.

Biocon Employees come together to sing our National Anthem to mark 75th Independence Day.

Itolizumab: Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19

DCGI Approval for emergency use of Itolizumab in treatment of Covid-19

Follow Biocon Biologics

BBL-X
BBL-Li
BBL-fb
BBL-Inst

Follow Biocon

Search

Biocon Limited

20th KM, Hosur Road,
Electronic City,
Bangalore, India - 560 100
Email: contact.us@biocon.com
+91 80 2808 2808 / 91 80 4014 4014

Archives

DISCLAIMER

Please read our Disclaimer and Comments Policy before engaging on our blog!

Create a website or blog at WordPress.com
  • Subscribe Subscribed
    • A Blog by Biocon
      • Join 121 other subscribers
    • Already have a WordPress.com account? Log in now.
    • A Blog by Biocon
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar

Loading Comments...